Introduction: What is a migraine and why does it require special attention?
Migraine is a complex neurological disorder characterized by severe, pulsating headaches, often accompanied by nausea, vomiting, and hypersensitivity to light and sound. Although in everyday speech migraine is often associated with "cerebral vessels," modern medicine views it as a multifactorial disease involving the nervous system, even though vascular changes may play a role in its manifestation. It is important to note that the term "monaya disease" is not a generally accepted medical name for any condition, and in this article, we will focus on modern methods of treating migraine based on the latest scientific data.
Chronic migraine significantly reduces patients' quality of life, leading to disability and significant economic costs associated with medical care and reduced productivity [2]. Finding effective and safe treatment methods remains a priority.
Innovative neuromodulation methods in migraine treatment
The development of neuromodulation technologies opens new perspectives in the treatment of chronic migraine, especially for patients who do not respond to standard therapy.
Magnetic Resonance-guided Focused Ultrasound Thalamotomy (MRgFUS VIM thalamotomy)
One such method is Magnetic Resonance-guided Focused Ultrasound Thalamotomy (MRgFUS VIM thalamotomy). Initially developed for the treatment of medication-resistant essential tremor, this procedure showed an unexpectedly positive effect in a patient with chronic migraine. In one described case, a 76-year-old woman with a 40-year history of chronic migraine, unresponsive to multiple types of treatment, underwent MRgFUS VIM thalamotomy to resolve severe essential tremor. After the procedure, not only did the tremor resolve, but her chronic migraines also ceased during a long-term follow-up. This case highlights the potential of neuromodulatory approaches for treating chronic pain, although further studies are required to confirm the efficacy and safety of MRgFUS VIM thalamotomy specifically for migraine [1].
Remote Electrical Neuromodulation (REN)
Another promising non-pharmacological method is Remote Electrical Neuromodulation (REN). This method is based on the concept of pain modulation, where the activation of peripheral nerves can induce descending pain inhibition in the brain. The Nerivio® device, which uses REN technology, is FDA-approved for the acute and preventive treatment of migraine in patients aged 8 and older. The mechanism of action of REN is associated with enhancing the Conditioned Pain Modulation (CPM) mechanism, which is deficient in people with migraine, helping the brain to interpret external stimuli that might otherwise trigger pain in a different way [4].
Psychological approaches and combating medication-overuse headache
Chronic migraine is often accompanied by medication overuse (CM-MOH), which can exacerbate the condition and increase healthcare costs. In such cases, comprehensive approaches that include psychological support demonstrate high efficacy.
Mindfulness-based programs
Research has shown that adding a mindfulness-based program to standard treatment for chronic migraine associated with medication overuse significantly reduces total treatment costs and increases its effectiveness. Over a 12-month follow-up period, patients who participated in the mindfulness program saw their total treatment costs decrease from €2620 to €1603, indicating the economic viability of such a multimodal approach. This underscores the importance of not only pharmacological but also psychotherapeutic methods in managing chronic pain [2].
Comprehensive approach and treatment perspectives
Effective treatment of migraine, especially chronic and refractory cases, requires a comprehensive, multimodal approach. This may include a combination of pharmacological agents, innovative neuromodulation techniques, and psychological support. It is important to consider the patient's individual characteristics, the presence of comorbidities, and their response to various types of therapy. For example, migraine is often a comorbid condition with other neurological disorders, such as Ménière's disease, which requires a careful approach to diagnosis and treatment [7].
Ongoing research in the fields of neurobiology and neuromodulation continues to expand our capabilities in combating migraine, offering hope for improving the quality of life for millions of people suffering from this debilitating disease.
Sources
- 1. Resolution of chronic refractory migraine and development of burning mouth syndrome after focused ultrasound thalamotomy: illustrative case. https://pubmed.ncbi.nlm.nih.gov/42184431/
- 2. Cost-efficacy evaluation of a mindfulness-based program added to treatment as usual for the treatment of chronic migraine associated to medication overuse headache. https://pubmed.ncbi.nlm.nih.gov/40555938/
- 3. The Mechanism of Action of Remote Electrical Neuromodulation (REN) in Treating Migraine and Potentially Other Idiopathic Pain Conditions. https://pubmed.ncbi.nlm.nih.gov/41307755/
- 4. Real-world analysis of Ménière's disease: treatment patterns, surgical trends, demographic disparities and co-morbidities using TriNetX data. https://pubmed.ncbi.nlm.nih.gov/42252840/
The information provided in this article is for reference purposes only and cannot replace professional medical advice. Always consult a qualified specialist for diagnosis and treatment prescription.